Aegerion Pharmaceuticals was acquired by Amryt Pharma plc 24 September 2019. Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a growing commercial business and a significant development pipeline. Please Follow us at https://www.linkedin.com/company/amryt-pharma-plc/
